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Background: It is thought that during development of the
periodontium, dental follicle cells, when appropriately triggered,
have the ability to differentiate into periodontal ligament fibro-
blasts, cementoblasts, and osteoblasts. However, the exact mech-
anisms/factors responsible for initiating cell differentiation are
not defined. The purpose of this in vitro study was to further
characterize follicle cells and to determine the effects of an
enamel matrix-derived protein (EMD) on these cells.
Methods: Murine follicle cells, transformed with simian virus
40 (SV 40) T antigen-containing virus (SVF cells), were used.
SVF cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) plus 2% fetal bovine serum (FBS) or 2% FBS plus EMD
(100 µg/ml), with and without ascorbic acid (50 µg/ml). For
proliferation assays, cells were plated at 500 cells/cm2 in 24-
well plates and counted on days 3, 4, and 5. For Northern analy-
sis, total RNA was isolated on days 8, 12, and 18. Induction of
mineral nodules by SVF cells was determined by von Kossa
staining.
Results: EMD had a significant proliferative effect on SVF
cells, when compared with 2% FBS control. Based on investi-
gations in situ, follicle cells at the time point used here do not
express key mineral-associated markers, e.g., osteocalcin (OCN)
or bone sialoprotein (BSP). Significantly, by day 12 in culture,
Northern analysis indicated that the follicle cells expressed tran-
scripts for BSP, OCN, and osteopontin (OPN). EMD increased
OPN mRNA and decreased OCN mRNA expression. SVF cells
were capable of inducing mineralization on day 18, but EMD
blocked this activity.
Conclusions: These results suggest the follicle cells have the
capacity to act as cementoblasts or osteoblasts. Furthermore,
EMD can regulate follicle cell activity, thus suggesting that epithe-
lial-mesenchymal interactions may be important during devel-
opment of periodontal tissues. J Periodontol 2001;72:679-687.
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T
he dental follicle, a loose connec-
tive tissue surrounding the un-
erupted tooth, is required for erup-
tion to occur.1-5 Beyond their critical role
during tooth eruption, follicle cells are
also thought to have the ability to differ-
entiate into periodontal cells (cemento-
blasts, periodontal ligament fibroblasts,
and osteoblasts) as required for devel-
opment of the periodontium.6 However,
the specific events, mechanisms, and
factors controlling follicle cell activities
during tooth eruption and periodontal tis-
sue formation remain undefined. The
studies here focused on determining the
potential regulators of follicle cell matu-
ration toward a “cementoblast-osteoblast”
phenotype.
Identifying specific factors and/or
mechanisms regulating development of
periodontal tissues will provide impor-
tant information as to which molecules
and cells are required for regeneration of
periodontal tissues lost as a consequence
of disease. To date, several candidate
cells and associated factors have been
identified, although their specific role in
controlling periodontal formation has not
been confirmed.7,8 Results from some
studies suggest, in a similar fashion to
enamel-dentin formation,9 that epithe-
lial-mesenchymal interactions are re-
quired for follicle cells to function as
cementoblasts, osteoblasts, or periodon-
tal ligament cells.10,11 For example, it
has been proposed that proteins derived
from enamel, e.g., amelogenin and/or
ameloblastin, may be involved in regu-
lating follicle cell maturation and/or
transformation of epithelial root sheath
(ERS) cells into cementoblasts.12,13
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In the studies here, we focused on the role of EMD‡
in controlling follicle cell behavior. EMD is a novel ther-
apeutic agent intended to promote regeneration of peri-
odontal tissues. EMD has been reported to contain a
protein complex belonging to the amelogenin family.14
Amelogenins are extracellular matrix components of
enamel which are considered by some to play an
important role in enamel mineralization.15-17 Studies
to date have reported that EMD has the capacity to
induce proliferation, migration, adhesion, mineraliza-
tion, and differentiation of cells, which are all events
involved in periodontal regeneration and healing.18,19
Heijl and colleagues reported that EMD was effective
in the treatment of intrabony defects in humans.20,21
Further studies, using EMD with and without barrier
membranes, have reported that EMD enhanced con-
nective tissue attachment and wound healing.22-25 In
addition, Hammarström and coworkers, using a mon-
key model, demonstrated that EMD enhanced forma-
tion of bone, cementum, and periodontal ligament.26
In vitro studies suggest that EMD can enhance the
synthesis of transforming growth factor-β in periodon-
tal ligament (PDL) cells27 and that this secondary effect
may, in part, explain some of the activities attributed
to EMD.
These studies suggest a positive role for EMD in
promoting cell activities as required during periodon-
tal wound healing. A major rationale indicated for using
EMD clinically is based on the hypothesis that epithe-
lial-mesenchymal interactions are required for matu-
ration of the developing periodontium and hence for
regeneration of periodontal tissues. To further define the
role of EMD in regulating mesenchymal cells, we
focused on determining the effects of EMD on the puta-
tive precursor cells of osteoblasts, cementoblasts, and
PDL fibroblasts; i.e., follicle cells.
MATERIALS AND METHODS
Cell Culture
Follicle cells were obtained from CD-1 mice at day 22
of development, where day 0 is defined as vaginal plug
date and mice are usually born on day 19. Selection
of this time point for isolation of follicle cells was based
on in situ data28,29 indicating that at this time, cells
within the local region do not express BSP or OCN, and
root formation (cementogenesis) has not been initi-
ated. The method used for cell isolation was similar to
that previously reported by Wise et al.1 Briefly, using
a dissecting microscope, first molars were removed
and then subjected to enzymatic digestion (collage-
nase type VII 0.6 mg/ml trypsin 0.25%)§ for 1 hour. To
immortalize cells following enzymatic digestion, cells
were resuspended in 25 ml Dulbecco’s modified
Eagle’s medium (DMEM) containing 2% fetal bovine
serum (FBS) and simian virus 40 (SV40) at a multi-
plicity of infection of 100. Epithelial cells did not sur-
vive in this media, as determined by lack of expres-
sion for specific keratins¶ (data not shown). After infect-
ing for 2 hours in suspension, cells were plated with
an equal volume of media containing 20% FBS. Media
were removed the next day and replaced with DMEM
containing 10% FBS. To confirm infection with virus,
expression of SV40 TAg was determined by Northern
analysis, using a large T-antigen probe (mouse osteo-
calcin promoter driven T-antigen in pUC) obtained
from Dr. Jolene Windle.30 Cells were subsequently
screened for TAg by immunohistochemistry using a
polyclonal antibody to SV40 large T antigen# detected
with a peroxidase kit,¶ and were found to be uniformly
positive (data not shown). Infected follicle cells were
named SVF cells, and were maintained in DMEM plus
10% FBS containing 100 U/ml of penicillin and 100
µg/ml streptomycin in a humidified atmosphere of 5%
CO2 at 37°C.
Enamel Matrix Protein
EMD was generously provided by the manufacturer.‡
The dose selected for the studies reported here was
based on our previous investigations with cemento-
blasts and osteoblasts, where EMD at 100 g/ml
altered both cell proliferation and gene expression.31
Cell Proliferation
Follicle cells were plated at 500 cells/cm2 in triplicate
wells of 24-well dishes in DMEM with 10% FBS and
allowed to adhere overnight. On the following day,
media were changed and cells treated with: 2% FBS
or 2% FBS + EMD (100 µg/ml), with and without ascor-
bic acid (50 g/ml). For proliferation assays, cells
were harvested on days 3, 4, and 5 using trypsin/EDTA
and cell number determined using a Coulter counter.
Experiments were repeated 2 times.
Morphology
A microscope** was used to take images of follicle
cells on days 8, 12, and 15.
Northern Blot Analysis
To determine gene expression, follicle cells were plated
in 100 mm cell culture dishes†† at 5,000 cells/dish.
Cells were allowed to adhere for 24 hours in DMEM
with 10% FBS, after which media were changed to
DMEM with 2% FBS with 100 µg/ml EMD, ± ascorbic
acid (AA, 50 µg/ml). Media with 2% FBS served as a
control. Total RNA was isolated on days 8, 12, and 18
with Trizol  and RNA concentration quantified by spec-
trophotometer. RNA (5 µg) was denatured, fractionated
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‡  Emdogain, Biora AB, Malmö, Sweden.
§  Sigma Chemical Co., St. Louis, MO.
 Gibco BRL, Gaithersburg, MD.
¶  Dako Corporation, Carpinteria, CA.
#  PharMingen, San Diego, CA.
** Axiovert 35, Carl Zeiss, Inc., Thornwood, NY.
†† Falcon, Becton Dickinson, Franklin Lakes, NJ.
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on a 6% formaldehyde, 1.2% agarose gel and
transferred to nylon membrane‡‡ and cross-
linked by UV radiation.‡‡
Blots were hybridized with random primed
32P labeled probes§§ and exposed to film with
intensifying screens at −70°C for 24 to 48 hours.
Probes used for Northern blots were BSP = M-
BSP consisting of 1 kb of mouse cDNA in PCR
II32 (a gift from Drs. M. Young and L. Fisher,
NIDCR/NIH, Bethesda, Maryland); OPN = MOP-
3 consisting of 1 kb of mouse OPN cDNA in
PCR II33 (a gift from Drs. M. Young and L.
Fisher); and OCN = 400 bp of mouse OCN
cDNA originally cloned into pSP65 cloning vec-
tor was transferred to Bluescript SK34 (obtained
from Dr. J. Wozney, Genetic Institute, Cam-
bridge, Massachusetts). Experiments were car-
ried out two times. An image analysis program 
was used to quantify data.
Mineralization Assay
Cells were plated at 1,000 cells/
well in 24-well plates in DMEM
containing 10% FBS. After 24
hours, the media were changed to
DMEM with or without 50 µg/ml
ascorbic acid (AA), with or with-
out EMD (100 µg/ml), and with
2% FBS and supplemented with
10 mM β-glycerophosphate.35,36
Biomineralization assays were
performed on days 8, 12, 18, and
24. Mineralization by SVF cells
was determined with von Kossa
staining.37 Experiments were per-
formed 3 times.
Statistical Analysis
For the proliferation assay, the  statistical analysis used
was 1-way analysis of variance (ANOVA). Tukey
Kramer multiple comparison tests also were performed.
RESULTS
Cell Proliferation
As shown in Figure 1 and Table 1, increased prolifer-
ation was noted in cells treated with ascorbic acid when
compared with appropriate controls. Addition of EMD
significantly enhanced cell proliferation in the absence
or presence of AA. This effect was apparent by day 4
of treatment.
Cell Morphology
Parallel to enhanced cell proliferation, changes were
noted in the morphology of follicle cells with time in
culture. Under normal culture conditions, follicle cells
exhibit a fibroblastic spindle-shaped morphology, but
with increasing days in culture they become cuboidal.
As shown in Figure 2, cells exposed to EMD exhibited
this cuboidal appearance at an early time point when
compared with cells not exposed to EMD, and this was
especially apparent at day 8 in EMD-treated cells with-
out AA as compared to the 2% FBS control. This
cuboidal appearance is similar to what is seen with
cementoblasts and osteoblasts. While morphology
alone is not necessarily indicative of phenotype, it does
distinguish these cells from fibroblastic cells, which
tend to maintain an elongated shape in culture even
when very confluent.
Northern Analysis
The next set of experiments was designed to deter-
mine whether proliferative and morphological changes
elicited by EMD were also reflected in changes in gene
expression pattern and in mineral nodule formation by
follicle cells.
Day 8. At this time point, follicle cells did not
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Figure 1.
Effect of EMD on follicle cell proliferation. Cells were maintained in media with 2%
FBS ± 50 µg/ml ascorbic acid and ± EMD.The 2% FBS group was used as a control.
Cell number was counted by Coulter counter on days 3, 4, and 5.These results were
reproduced in 2 separate experiments.
Table 1.
Statistical Analysis for Figure 1
Day 4 Day 5
2% FBS + EMD 2% FBS + EMD + AA 2% FBS + EMD 2% FBS + EMD + AA
2% FBS * * * *
2% FBS + AA ns† * ns† *
* P <0.001.
† Not significant.
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express markers associated with the
mature cementoblast/osteoblast phe-
notype, i.e., BSP and OCN (Fig. 3).
EMD-treated cells exhibited en-
hanced OPN transcripts in the pres-
ence and absence of ascorbic acid,
when compared to cells not treated
with EMD. Also, an increase in col-
lagen expression was noted in cells
exposed to EMD, with a more signif-
icant effect noted in the EMD plus
ascorbic acid group compared to the
ascorbic acid group.
Day 12. At day 12, follicle cells,
independent of addition of EMD,
expressed markers associated with
mineralized tissues, e.g., OCN and
BSP (Fig. 4). At this time point, the
ability of EMD to increase OPN and
collagen expression, as seen at day
8, was still observed, but now only
noted in the EMD plus AA-treated
cells when compared to AA-treated
cells. An increased expression of BSP
mRNA was observed in cells treated
with EMD when compared with
appropriate controls. The most dra-
matic finding was the effect of EMD
on OCN expression by follicle cells.
EMD almost completely abolished
the expression of OCN transcripts in
the absence of ascorbic acid. In the
presence of ascorbic acid, the ability
of EMD to downregulate OCN
expression, while still apparent, was
not as dramatic.
Day 18. At this time point, cells
treated with EMD plus AA retained
an enhanced expression of both OPN
and collagen mRNAs when com-
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Figure 2.
Effect of EMD on follicle cell morphology in vitro. For these studies, cells were cultured in media
containing 2% FBS ± 50 µg/ml AA and ± 100 µg/ml EMD. Note the increased number of cuboidal
cells in EMD groups versus 2% FBS groups, especially at day 8.
Figure 3.
Effect of EMD on gene expression by follicle
cells on day 8. A. Follicle cells were grown in
media containing 2% FBS ± AA and ± EMD,
and RNA isolated at day 8. Gene expression
for OPN, collagen type I (COL I), BSP, and OCN
was determined by Northern analysis. An 18S
probe was used to evaluate loading efficiency
and for normalization. Note increased
expression of COL I and OPN in cells exposed
to EMD. BSP and OCN transcripts were not
apparent at this time point. B. Normalization
expressed as gene/18S mRNA.These results
were noted in 2 separate experiments (Y axis:
relative value treated/control).
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for OCN mRNA independent of
the presence/absence of ascorbic
acid.
Mineralization. SVF cells were
capable of inducing mineralization
by day 18, with greater mineral
nodule formation noted by day 24.
EMD blocked SVF cell-mediated
mineralization in vitro (Fig. 6).
DISCUSSION
Tooth organogenesis (formation of
enamel and dentin) is dependent
on reciprocal and sequential
epithelial-mesenchymal interac-
tions, and this process is marked
by the appearance of specific
matrix macromolecules.38 In con-
trast, the mechanisms and cells
regulating cementum-periodontal
formation remain undefined. His-
tological investigations of peri-
odontal development suggest that
ectomesenchymal cells; that is,
dental papillae and dental follicle
cells, when triggered, appropri-
ately secrete the matrix required
for their differentiation into cemen-
toblasts, osteoblasts, and peri-
odontal ligament cells.39 More
recent studies provide evidence
that the trigger factors may be
derived from surrounding epithe-
lial cells, thus suggesting that
epithelial-mesenchymal interac-
tions are important for formation
of the periodontium.11,26
The present study focused on
isolating and characterizing folli-
cle cells in vitro and determining
their interaction with enamel
matrix proteins. The dental folli-
cle tissue contains a heteroge-
neous population of mesenchymal
cells, where Ten Cate and Mills
suggested that the dental follicle
gives rise to cementum, peri-
odontal ligament, and bone.40 In
their studies, they transplanted
tooth germs of hamster and mice
to subcutaneous sites in host animals and, by using tri-
tiated thymidine, demonstrated that the newly formed
cementum and periodontal ligament were derived from
the transplanted tissues.40 As an extension of these
studies, Yoshikawa and Kollar41 and Palmer and Lums-
den42 separated various parts of the murine tooth
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Figure 4.
Effect of EMD on gene expression by follicle cells on day 12. A. Follicle cells were grown in media
containing 2% FBS ± AA and ± EMD and RNA isolated at day 12. Gene expression for OPN,
collagen type I (COL I), BSP, and OCN was determined by Northern analysis. An 18S probe was used
to evaluate loading efficiency and for normalization. Importantly, at this time point, follicle cells
express markers for mineralized tissues, BSP, and OCN. EMD enhanced expression of transcripts for
COL I and OPN, but only for cells treated with EMD + AA compared to AA alone. Further, EMD
enhanced BSP mRNA, while downregulating OCN expression by follicle cells. B. Normalization
expressed as gene/18 S mRNA.These results were noted in 2 separate experiments (Y axis: relative
value treated/control).
pared with controls, 2% FBS plus AA (Fig. 5). Fur-
ther, enhanced collagen expression was noted in EMD-
treated cells versus 2% FBS alone. The ability of EMD
to enhance BSP mRNA, noted at day 12, was not
apparent at this time point. In contrast, by day 18,
cells exposed to EMD exhibited minimal expression
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germ, i.e., enamel organ, dental follicle, and papilla,
and used various recombinations of these tissues for
transplantation into the eye of host animals. These
studies supported the concept that follicle tissues are
critical for formation of both cementum and bone. The
results from the in vitro studies reported here, demon-
strating that follicle cells have the capacity to induce
mineralization and also to express gene markers asso-
ciated with the cementoblast and
osteoblast phenotype, support these
conclusions.
Importantly, in our studies, when
follicle cells were first isolated, they
did not express markers of the
mature cementoblast/osteoblast phe-
notype, paralleling the findings from
our in situ investigations.28,29 The
fact that, with time in culture, follicle
cells express BSP and OCN tran-
scripts suggests that a specific pop-
ulation of cells, not detected in situ,
were selected out or alternatively,
that cells, with time, begin to secrete
a matrix that supports differentiation
along the cementoblast/osteoblast
pathway. Recently, Hou et al.43
demonstrated that follicle cells in
vitro, isolated from day 25 mice tis-
sue, express type I and III collagen,
fibronectin, and alkaline phos-
phatase. Also, using in situ hybridiza-
tion, they reported BSP and OPN
gene expression at this time point in
cells within the developing root
region and also surrounding alveo-
lar bone, but not within the follicle
region. It was not clear whether the
cultured cells expressed transcripts
for OPN and BSP. Nevertheless, their
data, coupled with our findings and
past recombination studies, provide
strong evidence that follicle cells
have the capacity to function as
cementoblasts/osteoblasts.
Having demonstrated that these
cells express markers associated with
mature osteoblasts and cemento-
blasts, we were interested in deter-
mining whether enamel matrix-
derived proteins had the ability to
alter follicle cell gene expression and
induction of biomineralization in vitro.
As reported previously for human
periodontal ligament cells, pre-
osteoblast calvaria cell line (OCT-1),
osteoprogenitor cell line (MC3T3-
E1), and cementoblasts (OC-CM),14,31 EMD promoted
proliferation of follicle cells. Since many factors that
promote proliferation inhibit cell maturation, the effect
of EMD on gene expression and mineral nodule for-
mation by follicle cells was determined. In the absence
of EMD, SVF cells were capable of inducing mineral-
ization on day 18 (Fig. 6). EMD has been shown to
inhibit cementoblast-mediated mineral nodule forma-
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Figure 5.
Effect of EMD on gene expression by follicle cells on day 18. A. Follicle cells were grown in media
containing 2% FBS ± AA and ± EMD and RNA isolated at day 18. Gene expression for OPN,
collagen type I (COL I), BSP, and OCN was determined by Northern analysis. An 18S probe was
used to evaluate loading efficiency and for normalization. At this time point, EMD retained the
ability to promote OPN (+ AA only) and COL I (± AA) gene expression, while EMD had minimal
effect on BSP mRNA. In contrast, EMD, with or without AA, significantly downregulated OCN
expression. B. Normalization expressed as gene/18 S mRNA.These results were noted in 2
separate experiments (Y axis: relative value treated/control).
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tion.31 Consistent with these findings, in this study,
EMD totally blocked follicle cell-mediated mineral nod-
ule formation in vitro. In contrast to the studies here,
Gestrelius et al. showed that EMD promoted peri-
odontal ligament-mediated mineral formation.19 There
are several possibilities for these discrepancies, includ-
ing differences in cell types, species, and experimen-
tal design. The specific mechanisms by which EMD
decreased mineral nodule formation requires further
investigation. However, it is tempting to speculate that
EMD’s effect on mineral formation is related to the
evidence that EMD enhances the expression of trans-
forming growth factor (TGF)-β.27 Several laboratories
have shown that TGF-β inhibits cell-mediated mineral
nodule formation in vitro.44 Thus, the data here sug-
gest that some products from the surrounding epithe-
lial cells promote cell proliferation, providing a critical
mass of cells required for promoting mineralized tis-
sue formation; i.e., tooth root cementum and alveolar
bone, but that such products may also regulate the
extent of mineral formation and allow for development
of the periodontal ligament.
In parallel with determining the effects of EMD on
mineral nodule formation, the influence of EMD on
gene expression by follicle cells was assessed. The
most significant finding was the dramatic decrease in
OCN mRNA levels in EMD-treated follicle cells when
compared with 2% FBS control, as previously noted for
cementoblasts31 (Figs. 4 and 5). In addition, there was
also an increase in OPN expression at all time points,
with an increase in BSP transcripts noted at day 12.
In translating these in vitro findings into possible clin-
ical implications, it is important to review the activi-
ties attributed to OCN, BSP, and OPN. While the exact
role for OCN in the mineralization process is unknown,
OCN is specific to mineralized tissues and is
an early marker for cells undergoing miner-
alization. In addition, there is accumulating
evidence that OCN controls crystal growth.45
Osteocalcin-deficient mice provide evidence
that OCN inhibits bone formation, but not
dentin formation, by preventing bone matrix
deposition by osteoblasts.46 BSP and OPN,
both adhesion molecules containing RGD
domains, have been implicated as having a
role in regulating the migration and attach-
ment of cells to the local site. In terms of
cementum formation, it is possible that both
of these molecules promote adhesion of cells
onto the root surface as required for cemen-
tum formation. BSP, a mineral-selective mol-
ecule, also is implicated as having a key role
in promoting biomineralization.47 In contrast,
while OPN is found in high concentrations in
mineralized tissues, it is also found in several
other tissues and has been assigned various
functions. In terms of mineralized tissues, OPN may
serve as a regulator of crystal growth.48
Thus, based on the putative roles for OPN, BSP, and
OCN during mineralization, one might have anticipated
increased mineralization with the dramatic decrease
in OCN expression. There are several plausible expla-
nations for this finding, including the fact that there
are most likely several proteins controlling the miner-
alization process and that EMD is capable of regulat-
ing many of these factors, e.g., TGF-β as discussed
above, where the relative concentration of specific fac-
tors determines the extent of mineralization.
Translating these results to the clinical level, it is clear
that EMD influence cell activities, where a fundamen-
tal activity of EMD is to promote cell proliferation. Thus,
the time EMD remains at a site, coupled with the cells
that have been triggered by EMD, most likely deter-
mines the clinical outcome. In an ideal situation, EMD
may provide the critical cell mass for promoting bone-
cementum formation, while regulating crystal growth,
allowing for formation of a periodontal ligament. Clearly,
further investigations are required to identify the exact
role of follicle cells during development and to determine
the specific factors controlling follicle cell activities dur-
ing development. Identifying these factors should pro-
vide information necessary to design knowledge-based
regenerative periodontal therapies.
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Induction of mineralization by follicle cells in vitro. For these studies, cells were cultured
in media containing 2% FBS, 50 g/ml AA, 10 mM -glycerophosphate, and EMD at
100 µg/ml. On days 8, 12, 18, and 24, von Kossa staining was performed to
determine mineral nodule formation. Follicle cells started to induce mineralization by
day 18. Note increased mineral nodule formation on day 24. EMD blocked follicle cell-
mediated mineral nodule formation, and this effect was noted at both day 18 and
day 24.These results were noted in 3 separate experiments.
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